Annual report [Section 13 and 15(d), not S-K Item 405]

CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.26.3
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
12 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2024
CASH FLOWS FROM OPERATING ACTIVITIES      
Net increase (decrease) in net assets resulting from operations $ 31,996 $ 57,191 $ 94,506
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities:      
Purchase of investments (308,745) (396,796) (177,649)
Principal repayments on investments 204,139 262,753 133,471
Proceeds from sale of investments 5,402 89,838 6,750
Increase in investments due to paid-in-kind interest or other (7,094) (4,910) (5,525)
Net change in premiums, discounts and amortization 514 (846) 170
Net realized loss (gain) on investments and other (968) (55,642) (5,959)
Net unrealized depreciation (appreciation) of investments 11,460 42,739 (42,703)
Amortization of deferred financing costs 2,969 2,293 1,864
Changes in assets and liabilities:      
Decrease (increase) in interest receivable, net (727) 221 177
Decrease (increase) in funds due from administrative agent 846 (1,989) 134
Decrease (increase) in other assets, net (539) 457 (1,224)
Increase (decrease) in accounts payable and accrued expenses 131 (42) 224
Increase (decrease) in interest payable 4,144 225 (40)
Increase (decrease) in other liabilities 168 (54) (1,063)
Net cash provided by (used in) operating activities (56,698) (5,489) 3,240
CASH FLOWS FROM FINANCING ACTIVITIES      
Proceeds from line of credit 468,500 332,000 221,200
Repayments on line of credit (280,500) (402,600) (198,400)
Proceeds from issuance of notes payable 60,000 147,258 0
Redemption of notes payable (207,000) 0 0
Financing costs (1,829) (6,603) (686)
Proceeds from issuance of common stock 0 9,583 10,998
Proceeds from issuance of preferred stock 32,773 11,541 7,846
Redemption of preferred stock (1,095) 0 0
Offering costs for issuance of common stock 0 (144) (154)
Distributions paid to common stockholders (44,733) (55,480) (43,141)
Net cash provided by (used in) financing activities 26,116 35,555 (2,337)
NET INCREASE (DECREASE) IN CASH, CASH EQUIVALENTS, RESTRICTED CASH, AND RESTRICTED CASH EQUIVALENTS (30,582) 30,066 903
CASH, CASH EQUIVALENTS, RESTRICTED CASH, AND RESTRICTED CASH EQUIVALENTS, BEGINNING OF YEAR 32,370 2,304 1,401
CASH, CASH EQUIVALENTS, RESTRICTED CASH, AND RESTRICTED CASH EQUIVALENTS, END OF YEAR 1,788 32,370 2,304
Supplemental Cash Flow Elements      
CASH PAID DURING YEAR FOR INTEREST 20,825 19,761 21,755
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation [Abstract]      
Cash 69 596  
Cash equivalents 1,719 31,774  
Restricted cash 0 0  
Restricted cash equivalents 0 0  
Total cash, cash equivalents, restricted cash and restricted cash equivalents 1,788 32,370 2,304
Adviser      
Changes in assets and liabilities:      
Increase (decrease) in fee due to related party [1] (303) (968) 17
Administrator      
Changes in assets and liabilities:      
Increase (decrease) in fee due to related party [1] (91) 41 90
Investment, Unaffiliated and Affiliated Issuer, Excluding Other      
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities:      
Net realized loss (gain) on investments and other (2,778) (55,368) (2,008)
Net unrealized depreciation (appreciation) of investments 11,460 42,739 (42,703)
Other      
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities:      
Net realized loss (gain) on investments and other $ 1,810 $ (274) $ (3,951)
[1] Refer to Note 4—Related Party Transactions for additional information.